Search research articles
Contact Us
Filters
Showing results (101-110 of 177) with videos related to
Page
of 18
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 2, 2003
Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure
Lance A Smith, Michael J Jackson, Matthew J Hansard, et al.
Neuroscience Letters
|
January 28, 2012
Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor
Mahmoud M Iravani, Mona Sadeghian, Clement C M Leung, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 23, 2009
Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets
Bai-Yun Zeng, Robert H Balfour, Mike J Jackson, et al.
Neuroscience Letters
|
July 4, 2002
Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease
Kevin St P McNaught, Roger Belizaire, Peter Jenner, et al.
Experimental Neurology
|
November 23, 2006
Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets
Michael J Jackson, Lance A Smith, Ghassan Al-Barghouthy, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 20, 2010
Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets
Louisa Clare Johnston, Michael John Jackson, Sarah Rose, et al.
Molecules (Basel, Switzerland)
|
April 12, 2022
The Pharmacological Potential of Adenosine A<sub>2A</sub> Receptor Antagonists for Treating Parkinson's Disease
Akihisa Mori, Jiang-Fan Chen, Shinichi Uchida, et al.
Journal of Pharmacological Sciences
|
April 1, 2014
Adenosine A₂A-receptor antagonist istradefylline enhances the motor response of L-DOPA without worsening dyskinesia in MPTP-treated common marmosets
Shin-ichi Uchida, Tomomi Tashiro, Mika Kawai-Uchida, et al.
Journal of Neurochemistry
|
February 9, 2006
Pramipexole protects against MPTP toxicity in non-human primates
Mahmoud M Iravani, Claire O Haddon, J Mark Cooper, et al.
Psychopharmacology
|
February 4, 2014
Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats
Koji Yamada, Minoru Kobayashi, Shizuo Shiozaki, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 177) with videos related to
Sort By:
Page
of 18
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 2, 2003
Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposure
Lance A Smith, Michael J Jackson, Matthew J Hansard, et al.
Neuroscience Letters
|
January 28, 2012
Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor
Mahmoud M Iravani, Mona Sadeghian, Clement C M Leung, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 23, 2009
Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets
Bai-Yun Zeng, Robert H Balfour, Mike J Jackson, et al.
Neuroscience Letters
|
July 4, 2002
Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease
Kevin St P McNaught, Roger Belizaire, Peter Jenner, et al.
Experimental Neurology
|
November 23, 2006
Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets
Michael J Jackson, Lance A Smith, Ghassan Al-Barghouthy, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 20, 2010
Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP-treated common marmosets
Louisa Clare Johnston, Michael John Jackson, Sarah Rose, et al.
Molecules (Basel, Switzerland)
|
April 12, 2022
The Pharmacological Potential of Adenosine A<sub>2A</sub> Receptor Antagonists for Treating Parkinson's Disease
Akihisa Mori, Jiang-Fan Chen, Shinichi Uchida, et al.
Journal of Pharmacological Sciences
|
April 1, 2014
Adenosine A₂A-receptor antagonist istradefylline enhances the motor response of L-DOPA without worsening dyskinesia in MPTP-treated common marmosets
Shin-ichi Uchida, Tomomi Tashiro, Mika Kawai-Uchida, et al.
Journal of Neurochemistry
|
February 9, 2006
Pramipexole protects against MPTP toxicity in non-human primates
Mahmoud M Iravani, Claire O Haddon, J Mark Cooper, et al.
Psychopharmacology
|
February 4, 2014
Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats
Koji Yamada, Minoru Kobayashi, Shizuo Shiozaki, et al.
Page
of 18